Podcast


Presenter: G. Michael Allan MD CCFP James McCormack BSc(Pharm) PharmD

In episode 485, Mike and James go over a couple of COVID trials that show two different anti-inflammatories – colchicine and inhaled budesonide – seem to have an effect on reducing hospitalizations or urgent care visits.   1) Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial Lancet…

This content is for *CFPC Member Rate, CFPC Member Rate, Non-CFPC Member Rate, and Resident members only.
Login Join Now



CFPCLearn Logo

Listening to the Podcast can earn you MainPro+ Credits

Join Now

Already a CFPCLearn Member? Log in



Latest Podcasts

BS Medicine Episode #569: Statistics made simple and relevant – we promise – PART II

In episode 569, James and Mike continue to go over what statistics really show – we focus on what inferential statistics can and cannot do, what a p value means…
Listen 0.5 credits available

BS Medicine Episode #568: Statistics made simple and relevant – we promise

In episode 568, James and Mike go over what statistics really show – and importantly what they don’t show. We go over the terms and nuances and hopefully put them…
Listen 0.5 credits available

BS Medicine Episode #567: Industry and Us and You

In episode 567, Mike and James revisit the old topic of industry influence on health care providers. We go over the issues, the nuances and some of the latest evidence…
Listen 0.5 credits available

Presenter(s):

G. Michael Allan MD CCFP James McCormack BSc(Pharm) PharmD

This content is certified for MainPro+ Credits, log in to access


Presenter(s):

  • G. Michael Allan MD CCFP
  • James McCormack BSc(Pharm) PharmD

Spearkers do not have any conflicts of interest to declare.